Nventa
Navigation Links
Nventa in Medical News
Nventa announces change in Board of Directors
...her Board positions, was a tremendous asset to the nventa Board. We will miss her and wish her continued suc...l trial in women with cervical dysplasia." About nventa Biopharmaceuticals Corporation: nventa is developing innovative therapeutics for the trea...Nventa presents HspE7 data at international HPV conference
...eek in Beijing, China. HspE7 is being developed by nventa as a therapeutic vaccine for the treatment of dise... of action that is needed to clear the infection. nventa has previously shown that HspE7, a proprietary the... and activating cells of the immune system. About nventa Corporation: ------------------------- ...Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc.
...ies Inc. As a financier, Mr. Meekison has raised equity capital for various biotechnology companies such as StressGen Biotechnologies Corporation (now nventa Biopharmaceuticals Corporation), ID Biomedical Corp., Salix Pharmaceuticals Inc., Acorda Therapeutics Inc., Inex Pharmaceuticals Corporation, Nortran ...Nventa in Medical Technology
...vant
SAN DIEGO, Oct. 8 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals
Corporation (TSX: NVN) today pr... Poly-ICR into future internal product
candidates, nventa is pursuing the development of Poly-ICR for topica...l evolve into a revenue
generating opportunity for nventa in the near future."
About Poly-ICR:
Poly-ICR ...
...n cells and activating cells of the immune system. nventa is pursuing clinical development of HspE7 in combination with an adjuvant. About nventa Corporation: ------------------------- nventa is developing innovative therapeutics for the trea...
Nventa Develops Proprietary Vaccine Adjuvant
...ist SAN DIEGO, June 18 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an...s its consistency in physical-chemical properties. nventa has successfully manufactured research and develop...ccines against targeted antigens and pathogens." nventa intends to incorporate Poly-ICR into its future Co...Nventa to Present at Bio 2008 International Convention
... SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) announce...rld. The presentation will not be webcast. About nventa Biopharmaceuticals Corporation: nventa is developing innovative therapeutics for the trea...Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
...spE7 SAN DIEGO, May 12 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an...nical responses in patients with CIN. Accordingly, nventa believes that HspE7 may successfully induce a targ...le for a significant percentage of cases of CIN. nventa is currently working with the U.S. Food and Drug A...Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
... - SAN DIEGO, April 24 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an...linical responses in patients with CIN. Therefore, nventa believes that HspE7 may successfully treat CIN by ...ate enrollment by mid-2008." In addition to CIN, nventa is currently evaluating HspE7 as a potential treat...Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
...it SAN DIEGO, March 26 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an...ngs will be released in the next several months. nventa is currently working with the FDA to finalize tria...n patients in CIN in mid-2008. In addition to CIN, nventa is currently evaluating HspE7 as a potential treat...Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
... SAN DIEGO, March 11 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an...reby stimulating cellular immune system responses. nventa is developing new HspE7 for multiple indications. About nventa Corporation: ...Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
...y - SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an... is expected shortly. At the end of each cohort, nventa is also collecting immunological data that may pro...reby stimulating cellular immune system responses. nventa is developing HspE7 + Poly-ICLC for multiple indic...Initiation of Coverage Informational Review Issued by Scimitar Equity Research
... Scimitar Equity Research, Inc. issues a review on nventa Biopharmaceuticals Corporation (TSX: NVN) entitled... website: http://www.scimitarequity.com . About nventa Corporation: nventa is developing innovative therapeutics for the trea......n cells and activating cells of the immune system. nventa is pursuing clinical development of HspE7 in combination with an adjuvant. About nventa Corporation: ------------------------- nventa is developing innovative therapeutics for the trea...
Nventa in Biological Technology
... SAN DIEGO, Nov. 11 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals
Corporation (TSX: NVN) today an...her human papillomavirus (HPV) therapeutics. o nventa presented positive data from preclinical studies u...d 11 target antigens.
"During the quarter, nventa announced positive clinical results for our
lead c...
Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR
... M&A SAN DIEGO, Oct. 8 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN), a compa...nt for both therapeutic and prophylactic vaccines. nventa is currently advancing Poly-ICR as a means for rev... internal development. -- Partnering Poly-ICR -- nventa is currently providing Poly-ICR through Material T...Nventa Appoints Gordon H. Busenbark to Board of Directors
...ce - SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) announce...in corporate finance and manufacturing, will serve nventa well as we continue to advance our lead product ca...ard to collaborating with the other members of the nventa board and leveraging my industry experience to hel...Nventa Appoints John Varian to Board of Directors
...ise - SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) announce...and acquisitions should be extremely beneficial to nventa as it grows internally and continues its path to c...nal Conference. "I am proud to join the board at nventa Biopharmaceuticals, a truly innovative company tha...Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
... - SAN DIEGO, March 13 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation announced today fin...ess specified otherwise, are in Canadian dollars. nventa reported a net loss of $12,413,000, or $0.06 per s..., which generated gross proceeds of $24,807,000. nventa also reported a net loss of $2,319,000, or $0.01 p...Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial
...In addition to safety and tolerability assessment, nventa will also collect immunological data from these pa...and activating cells of the immune system. About nventa Corporation: ------------------------- nventa is developing innovative therapeutics for the trea...Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results
...ess specified otherwise, are in Canadian dollars. nventa reported a net loss of $3.1 million or $0.01 per s...of $14.3 million as of September 30, 2007. RECENT nventa HIGHLIGHTS - Initiated and dosed the first coh...progress our preclinical pipeline as well." About nventa Biopharmaceuticals Corporation: -----------------...Nventa updates progress of cervical dysplasia trial with new HspE7
...In addition to safety and tolerability assessment, nventa will also collect immunological data from these pa... and activating cells of the immune system. About nventa Corporation: ------------------------- nventa is developing innovative therapeutics for the trea...Nventa's CEO to present at two upcoming investor conferences
...emove any extra spaces if necessary.) About nventa Biopharmaceuticals Corporation: -------------------------------------------- nventa is developing innovative therapeutics for the trea... under the symbol NVN. For more information about nventa Biopharmaceuticals Corporation and access to the B...Nventa announces publication of HspE7 data
...ng clinical development of new HspE7 (HspE7 dosed with an adjuvant). About nventa Corporation: ------------------------- nventa is developing innovative therapeutics for the treatment of viral infections...Other TagsVerdiVariaVariaVariaVariaVariaVariaVariaPliersSLOSLOSLOSLOSLOOther Contentsimmunofluorescenceimmunofluorescenceimmunofluorescenceimmunofluorescenceimmunoglobulinimmunoglobulinimmunoglobulinimmunoglobulinimmunoglobulinimmunoglobulinimmunoglobulinimpactedimpactedimpactedimpactedimpactedimmunosuppressantimmunosuppressantimmunosuppressantimmunosuppressantcardioverter
(Date:11/26/2009)... get a bigger thrill when on an emotional rollerco... (HealthDay News) -- Call it the fear factor meets...s that spectators -- especially those who root for...on if it,s a closely contested match and victory w...despair. , Chew on that this Thanksgiving weeke...
(Date:11/26/2009)... Dr. David Kim of the Live Li...surgery in Dallas , is one of a growing number of ...cial networking sites to connect with individuals ...nt to fight morbid obesity. Dr. Kim is utilizing F...mation about his practice with the community. , ...
(Date:11/26/2009)... Benton Communications announ... growth system for retailers struggling to make an...WEB) November 26, 2009 -- Flu fears is the type of... the emergency room, according to Dr. David Benton...eleased business growth system – The Rfacto...
(Date:11/25/2009)..., EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whe...st.Butachiropractorcanalsogivepatientsthehelptheyn...swhereyourjaw(mandible)contacts/connectswithyoursk...ciatedwithTMJdysfunctionarepainwithchewing,clickin...fromTMJdysfunctionincluding:headaches,fatigue,slee...
(Date:11/25/2009)..., EMERYVILLE,Calif.,Nov.25/PRNewswire-FirstCall/...nouncedthatthecompanywillhosttwoinvestoreventsinDe...09-9:00a.m.CT/10:00a.m.ET ,, Principalinvesti...lzomibinrelapsedand/orrefractorymultiplemyeloma,as...nnualMeetingandExpositioninNewOrleans,LA.Theteleco...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2[0] Watching the Nail-Biting Big Game Hurts So Good[1] Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients[1] Pharmacist Injects Cure for Ailing Businesses [1] TMJ and Chiropractic Care: An Overall Wellness Approach[0] Onyx Pharmaceuticals Announces December 2009 Investor Events
(Date:11/25/2009)...refighters, police officers and ambulance workers ...e Center complex. They battled to save people from...s, tackled fires and evacuated as many people as t...17,000 people. And making their jobs even harder w...workers and their relatives jammed mobile networks...
(Date:11/25/2009)...you eat may be just as vital to your health as wha... for Biological Studies. Their experiments in mice...sands of genes in the liverthe body,s metabolic cl... not by the body,s circadian clock as conventional...he activity of a large number of genes completely ...
(Date:11/24/2009)...akened and flabby arteries from collapsing have be...tents are no longer needed -- once the arteries ar...y, doctors had no choice but to leave them in plac...ty,s Department of Biomedical Engineering has deve...ries drugs where they,re needed, then dissolves. ,...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2New piece found in the puzzle of epigenetics 8855 1New piece found in the puzzle of epigenetics 8855 2Two Companies Expand in Ann Arbor Area With MEDC Support 49046 1Two Companies Expand in Ann Arbor Area With MEDC Support 49046 217 of Americas Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences 49041 117 of Americas Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences 49041 217 of Americas Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences 49041 317 of Americas Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences 49041 417 of Americas Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences 49041 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |